Les instruments de gestion des déchets en Région wallonne (Belgique) : quels régimes de proximité ?
Scientific conference (2014, December 08)Detailed reference viewed: 24 (0 ULg)
Instruments de gestion économique des crises sanitaires touchant les animaux de production en Europe
Vandeputte, Sébastien ; Humblet, Marie-France ; Fecher-Bourgeois, Fabienne et al
in Revue Scientifique et Technique / Office International des Epizooties = Revista Cientifica y Tecnica / Officina Internacional de Epizootias = Scientific and Technical Review / International Office of Epizootics (2011), 30(3), 683-701
The importance of animal health crises has considerably increased over the last few years. When a crisis occurs, farmers can receive financial support through various public, private and mixed ... [more ▼]
The importance of animal health crises has considerably increased over the last few years. When a crisis occurs, farmers can receive financial support through various public, private and mixed compensation schemes. Economic losses resulting from diseases may be direct and indirect. If a disease is covered by European Union regulations then countries have a legal obligation to partly compensate farmers for direct losses, either directly through the national budget, or through a specific fund. The European Veterinary Fund also cofinances these losses. Only a few countries provide compensation for indirect losses. The private insurance sector also provides protection against some direct and indirect losses but the risks covered are variable. To encourage farmers to subscribe to this kind of insurance, some public authorities provide subsidies to help pay the premium. Insurance companies do not generally cover the risks linked to contagious diseases, but some companies do extend cover to include this type of risk. Several alternatives, such as mutual funds, are available to improve risk coverage. There is a lack of harmonisation among the various compensation schemes of different countries. Public authorities cannot provide full compensation, but mutual funds and private insurance companies are alternatives that should be further investigated and their use should be extended to other countries. A classification of diseases would harmonise the situation at the European level. [less ▲]Detailed reference viewed: 57 (9 ULg)
Instruments for collective design in a professional context : Digital format or new processes
Ben Rajeb, Samia ; Leclercq, Pierre
in Proceedings of the eighth International Conference on Advances in Computer-Human Interactions, ACHI 2015 (2015)Detailed reference viewed: 34 (5 ULg)
Instruments normatifs à valeur indicative et recevabilité du recours au Conseil d'Etat - Vers une restructuration des instruments normatifs d'aménagement du territoire ?
in Revue de Jurisprudence de Liège, Mons et Bruxelles (2011), (30), 1482-1489Detailed reference viewed: 49 (10 ULg)
Instruments souples, instruments non contraignants, instruments du marché : une alternative pertinente ?
in JADOT, Benoît (Ed.) Acteurs et outils du droit de l'environnement. Développements récents, développements (peut-être) à venir (2010)
The question is whether the traditional administrative law instruments, authoritarian, are best suited for environmental protection. The rational economic agent or capitalist is not naturally inclined to ... [more ▼]
The question is whether the traditional administrative law instruments, authoritarian, are best suited for environmental protection. The rational economic agent or capitalist is not naturally inclined to protect the environment. The environmental law almost always must thwart individual liberty and the pursuit of profit or comfort. Consequently, consensual and non-binding instruments are not the most naturally suited to protecting the environment. The main legal instruments of environmental law are reviewed: prohibition, authorization, non-legal action, gentlemen's agreements, contracts, tax incentives, market pollution… [less ▲]Detailed reference viewed: 81 (4 ULg)
L'insuffisance cardiaque du sujet age.
D'ORIO, Virginie ; LANCELLOTTI, Patrizio ; Pierard, Luc
in Revue medicale de Liege (2014), 69(5-6), 309-14
Heart failure in the elderly represents a major public health problem.In this population, the general objective of therapy, defined by current guidelines, does not differ from that proposed for younger ... [more ▼]
Heart failure in the elderly represents a major public health problem.In this population, the general objective of therapy, defined by current guidelines, does not differ from that proposed for younger patients: the aims are to decrease symptoms, to improve quality of life, to decrease hospitalizations, and to increase survival. However, in this category of patients, respect for autonomy and quality of life remains a priority, and requires a personalized approach because of the geriatric characteristics of many patients. [less ▲]Detailed reference viewed: 48 (6 ULg)
Insuffisance cardiaque et diabete
; Lancellotti, Patrizio ; Pierard, Luc
in Revue Médicale de Liège (2005), 60(5-6, May-Jun), 536-40
Diabetic patients frequently develop heart failure and have a guarded prognosis because of the combination of diabetic cardiomyopathy, hypertension and ischaemic heart disease. The lack of patient ... [more ▼]
Diabetic patients frequently develop heart failure and have a guarded prognosis because of the combination of diabetic cardiomyopathy, hypertension and ischaemic heart disease. The lack of patient awareness of the association between diabetes and cardiovascular disease contributes to the risk of heart failure in the diabetic population. Therefore, physicians should consider the risk of comorbidities and use appropriate screening tests to achieve early identification and initiate preventive strategies. There is evidence suggesting that adequate glycaemic control may improve cardiac metabolism and myocardial function in diabetics with heart failure. Improvement in cardiac function engendered by neurohumoral inhibition is associated with a decrease in mortality that is at least as great in the diabetic patients with heart failure as it is in the non diabetic patients. However, several therapeutic interventions have not yet been specifically validated in diabetic subjects. Thus, physicians should be encouraged to use therapies tested in the diabetic population, such as B-blockers and ACE inhibitors. Diabetic patients would benefit from more aggressive preventive programs aimed at reducing the incidence of cardiovascular morbidity and mortality. [less ▲]Detailed reference viewed: 12 (4 ULg)
Insuffisance cardiaque et diabete de type 2: une relation a double sens.
De Flines, Jenny ; Scheen, André
in Revue Médicale de Liège (2007), 62(2), 112-7
The present article analyses the intimate relationship between diabetes mellitus and congestive heart failure. This relationship is indeed "bidirectional". On the one hand, it is well known that diabetes ... [more ▼]
The present article analyses the intimate relationship between diabetes mellitus and congestive heart failure. This relationship is indeed "bidirectional". On the one hand, it is well known that diabetes mellitus, especially type 2 diabetes, predisposes to congestive heart failure due to intricated mechanisms. In most cases, there is a combination of various well-known risk factors, such as obesity, arterial hypertension and coronary heart disease, with a specific diabetic cardiomyopathy, whose pathophysiology is complex. On the other hand, several studies showed that congestive heart failure increases the risk of new type 2 diabetes, probably due to decreased muscular perfusion and excessive neurohumoral response. Remarkably, such a risk could be reduced by a drug capable of inhibiting the renin-angiotensin system, as previously reported in patients with arterial hypertension. The recent launch and the increasing use of thiazolidinediones (glitazones) raise the interest for congestive heart failure in diabetic patients. Indeed, because of their positive effect on insulin resistance and various pleiotropic effects, glitazones may exert some cardiovascular protection; however, both rosiglitazone and pioglitazone are associated with fluid retention, which could reveal or aggravate episodes of congestive heart failure. [less ▲]Detailed reference viewed: 112 (1 ULg)
Insuffisance hépatique aigue: traitement conservateur et alternatives thérapeutiques
Conference (2015, November 17)Detailed reference viewed: 27 (2 ULg)
Insuffisance hépatique et rénale secondaire à une intoxication au trichloréthylène
Misson, Jean-Paul ; ; et al
in Acta Paediatrica Belgica (1983)Detailed reference viewed: 17 (3 ULg)
Insuffisance hypophysaire et amaurose subaiguës causées par une pseudotumeur inflammatoire extensive du sinus sphénoïde
Hansen, Isabelle ; Petrossians, Patrick ; et al
in XVI Congrès de la Société Française d'Endocrinologie - Abstract book (1998)Detailed reference viewed: 46 (0 ULg)
L’insuffisance mitrale chez le cheval : revue de la littérature et comparaison avec la pathologie chez l’homme et chez le chien
; Leroux, Aurélia ; Amory, Hélène
in Annales de Médecine Vétérinaire (2013), 157(1), 52-68
Abstract Mitral regurgitation (MR) is a one of the most common cardiac disease in the equine species. Furthermore, it is the valvular disease that presents the higher risk to be associated with reduced ... [more ▼]
Abstract Mitral regurgitation (MR) is a one of the most common cardiac disease in the equine species. Furthermore, it is the valvular disease that presents the higher risk to be associated with reduced athletic performance, to evolve into congestive heart failure and to become life threatening. The clinical diagnosis of MR depends mainly on the expertise of the veterinarian in cardiology and is above all based on cardiac auscultation. In all of the cases, the definitive diagnosis and the evaluation of the disease severity require performing a Doppler echocardiographic examination. Signs of left ventricular and/or left atrial overload, large regurgitation jet, pulmonary arterial hypertension or significant arrhythmias are negative prognosis factors. Clinical signs of congestive heart failure make the prognosis worse. Other echocardiographic parameters are used in human and dogs in order to determine the severity of the MR, but have been not validated in horses. Treatment of mitral regurgitation in the equine species is symptomatic and directed against the development of a congestive heart failure. A lot of drugs that are used in human or dogs are of limited value in horses for financial reasons and/or lack of pharmacokinetics and pharmacologic data in equine species. [less ▲]Detailed reference viewed: 84 (33 ULg)
L’insuffisance mitrale chez le cheval : revue de littérature.
; Amory, Hélène ; Sandersen, Charlotte
in Pratique Vétérinaire Equine (2003), 35Detailed reference viewed: 38 (2 ULg)
L'insuffisance mitrale dynamique : rôle de l'échocardiographie d'effort
Post doctoral thesis (2005)Detailed reference viewed: 8 (1 ULg)
L'insuffisance mitrale ischemique.
Lancellotti, Patrizio ; Moonen, Marie ; et al
in Archives des Maladies du Coeur et des Vaisseaux (2007), 100(12), 1056-62
Mitral regurgitation (MR) is a serious complication of coronary heart disease. The functional form is the most frequent, often presenting with a dynamic character. The presence, and in particular the ... [more ▼]
Mitral regurgitation (MR) is a serious complication of coronary heart disease. The functional form is the most frequent, often presenting with a dynamic character. The presence, and in particular the severity of MR and its dynamic character have a major impact on the medium and long term prognosis. The mechanisms responsible for MR are complex and occur in a state of disequilibrium between traction forces and closing forces, for which the significance is partly affected by the presence of asynchrony in left ventricular contraction. The therapeutic management of these patients is difficult. In cases of proven asynchrony, implantation of a biventricular pacemaker is justified. A mitral surgical procedure may be envisaged in cases of severe MR where bypass surgery is planned. In cases of moderate MR at rest, an evaluation of its dynamic character on effort can assist with the decision to undertake combined surgery. Mitral regurgitation (MR) is a common and serious complication of ischemic heart disease. Three general forms are distinguished: MR related to acute rupture of the mitral pillar, ischemic MR and functional MR. [less ▲]Detailed reference viewed: 74 (7 ULg)
L'insuffisance mitrale par degenerescence myxoide: aspect biochimique et considerations physiopathologiques.
Radermecker, Marc ; Boulanger, Kevin ; Hulin, Alexia et al
in Revue Médicale de Liège (2008), 63(4), 187-92
Mitral valve is a complex structure which is submitted to repeated mechanical constraints. In clinical practice, an increasing incidence of mitral insufficiency resulting from myxomatous degeneration is ... [more ▼]
Mitral valve is a complex structure which is submitted to repeated mechanical constraints. In clinical practice, an increasing incidence of mitral insufficiency resulting from myxomatous degeneration is observed. Since myxomatous degeneration is also observed in defined genetic diseases of connective tissues, we propose the hypothesis that idiopathic mitral insufficiency might result from a minor alteration of the interstitial valvular cells and/or their interactions with their support. After a brief review of the role of the extracellular matrix in the heart, some histopathological and biochemical aspects of myxomatous degeneration are presented. Our data and those of the literature will be summarized and a physiopathological hypothesis proposed for myxomatous mitral valve degeneration. [less ▲]Detailed reference viewed: 290 (7 ULg)